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Association of brain-derived neurotrophic factor valine to methionine polymorphism 
with sexual dysfunction following selective serotonin reuptake inhibitor treatment in 
female patients with major depressive disorder 
 
ABSTRACT 
 
Introduction: The occurrence of female sexual dysfunction (FSD) in patients with major 
depressive disorder (MDD) receiving selective serotonin reuptake inhibitors (SSRIs) 
treatment gives negative impacts on patients' quality of life and causes treatment 
discontinuation. We aimed to investigate whether genetic polymorphism of identified 
candidate gene is associated with FSD in our study population.  
 
Methods: This is a cross-sectional study. A total of 95 female patients with MDD who met 
the criteria of the study were recruited and were specifically assessed on the sexual function 
by trained psychiatrists. Patients' DNA was genotyped for BDNF Val66Met polymorphism 
using real-time polymerase chain reaction.  
Results: The prevalence of FSD in this study is 31.6%. In the FSD group, patients with 
problematic marriage were significantly more frequent compared with patients who did not 
have problematic marriage (P=0.009). Significant association was detected in the lubrication 
domain with BDNF Val66Met polymorphism (P=0.030) using additive genetic model, with 
even stronger association when using the recessive model (P=0.013).  
 
Discussion: This study suggested that there was no significant association between BDNF 
Val66Met with FSD. However, this polymorphism is significantly associated with lubrication 
disorder in patients treated with SSRIs. 
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